Paterson Robert W, Boyle Kevin J, Parmeter Christopher F, Neumann James E, De Civita Paul
Industrial Economics, Inc., Cambridge, MA, USA.
Health Econ. 2008 Dec;17(12):1363-77. doi: 10.1002/hec.1336.
Promoting cessation is a cornerstone of tobacco control efforts by public-health agencies. Economic information to support cessation programs has generally emphasized cost-effectiveness or the impact of cigarette pricing and smoking restrictions on quit rates. In contrast, this study provides empirical estimates of smoker preferences for increased efficacy and other attributes of smoking cessation therapies (SCTs). Choice data were collected through a national survey of Canadian smokers. We find systematic preference heterogeneity for therapy types and SCT attributes between light and heavy smokers, as well as random heterogeneity using random parameters logit models. Preference heterogeneity is greatest between length of use and types of SCTs. We estimate that light smokers would be willing to pay nearly $500 ($CAN) to increase success rates to 40% with the comparable figure for heavy smokers being near $300 ($CAN). Results from this study can be used to inform research and development for smoking cessation products and programs and suggest important areas of future inquiry regarding heterogeneity of smoker preferences and preferences for other health programs.
促进戒烟是公共卫生机构控烟工作的基石。支持戒烟项目的经济信息通常强调成本效益或香烟定价及吸烟限制对戒烟率的影响。相比之下,本研究提供了吸烟者对提高戒烟疗法(SCT)疗效及其他属性的偏好的实证估计。选择数据是通过对加拿大吸烟者的全国性调查收集的。我们发现,轻度和重度吸烟者在治疗类型和SCT属性方面存在系统性的偏好异质性,同时使用随机参数logit模型发现了随机异质性。使用时间和SCT类型之间的偏好异质性最大。我们估计,轻度吸烟者愿意支付近500加元将成功率提高到40%,重度吸烟者的可比数字接近300加元。本研究结果可用于为戒烟产品和项目的研发提供信息,并为未来关于吸烟者偏好异质性及对其他健康项目偏好的重要研究领域提供建议。